Atlas Trials

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Clinical trial NCT00172003 · COMPLETED

Trial details

NCT number
NCT00172003
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Cell CancerNeoplasm Metastasis
Start date
2004-09-01
Primary completion
2009-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.